Terry Duffy, Chairman and Chief Executive Officer of CME Group, stated:
Sean has provided exemplary leadership for our financial product businesses over the past ten years, including the successful migration of SOFR derivatives to become the best tool for short-term interest rate hedging. Tim McCourt has a wealth of experience in financial products and is able to lead these vital business lines, which allow clients to manage their risk in key asset class.
McCourt joined CME Group in 2013 as Executive Director, Equity Index Products and has served as Global Head of Equity & FX Products since February 2022. In his new role, he will oversee the company’s interest rates, equity index, foreign exchange and cryptocurrency futures and options markets. Additionally, he will be responsible for the company’s BrokerTec cash treasuries platform and EBS spot FX platform.
The post Tim McCourt appointed as CME Group’s Global Head of Financial & OTC Products appeared first on LeapRate.